期刊文献+

呼吸重症监护病房多重耐药鲍曼不动杆菌耐药基因检测及耐药性分析 被引量:10

Detection and analysis of drug-resistant genes of multi-drug resistant Acinetobacter baumannii in respiratory intensive care unit
下载PDF
导出
摘要 目的了解呼吸重症监护病房内多重耐药鲍曼不动杆菌(MDR-AB)β-内酰胺酶基因和耐消毒剂磺胺复合物基因(qacE△1-sull)的耐药性,为临床的合理用药提供依据。方法对分离出的39株MDR-AB采用聚合酶链反应(PCR)及序列分析方法检测耐药基因,并且进行耐药性分析。结果 39株MDR-AB中28株碳青霉烯酶-23(OXA-23)阳性(71.8%),OXA-51阳性39株(100%),青霉素酶(TEM)阳性7株(17.9%),二十二碳六烯酸(DHA)阳性6株(15.4%),丝氨酸酶(PER)阳性5株(12.8%),头孢菌素酶(AmpC)阳性23株(59.0%),qacE△1-sull阳性39株(100%)。OXA-23和AmpC同时阳性17株(43.6%)。OXA-24,OXA-58,内膜蛋白酶-1(IMP-1),IMP-4,波形蛋白酶(VIM-2)和产巯基变量型(SHV)均未检出。在呼吸重症监护病房分离出来的菌株对哌拉西林、头孢他啶、环丙沙星、氨苄西林、头孢哌酮、头孢克洛、头孢唑啉的耐药率均>90%,对多黏菌素B的敏感率为100%。结论本院呼吸重症监护病房内MDR-AB主要携带的β-内酰胺酶基因为OXA-23和AmpC,根据其院内感染特征,为控制其传播,临床应加强有效的监测和隔离工作。 Objective To investigate the antimicrohial resistance of β-lactamase gene and disinfectants- sulfanilamide-resistance(qacE△1-sull) gene in multi-drug resistant Acinetobacter baumannii(MDR-AB) in respiratory intensive care unit. To provide evidence for rational antibiotics administration. Methods Thirty-nine strains of MDR- AB were separated. The related genes were analyzed by polymerase chain reaction (PCR) and verified by DNA sequencing. Results In thirty-nine strains of MDR-AB, the positive rates of carbapenemase (OXA-23), OXA-51, penicillinase(TEM), docosahexaenoic acid (DHA), serinase (PER), cephalosporinase (AmpC) and qaeEAl-sull were 71.8%, 100%, 17.9%, 15.4%, 12.8%, 59.0%, 100%. Both OXA-23 and AmpC were identified in 43.6% (17/39) strains. While IMP-l, IMP-4, OXA-24, OXA-58, sulphydryl variable(SHV) and vimentin(VIM-2) were not identified. In the respiratory intensive care unit, the resistant rates of the separated strains to piperacillin, ceftazidime, ciprofloxacin,ampicillin, efoperazone, cefaclor and cefazolin were more than 90%, and the sensitivity rates of the separated strains to polymyxin B were 100%. Conclusion OXA-23 and AmpC are the major β-lactamase genes carried on MDR-AB in the respiratory intensive care unit. According to the clinical infection characteristics,effective monitoring and quarantine work should be strengthened for controlling the epidemic of these strains.
出处 《临床荟萃》 CAS 2012年第19期1684-1686,1690,共4页 Clinical Focus
关键词 交叉感染 呼吸监护病房 鲍氏不动杆菌 多药耐药相关蛋白质类 聚合酶链反应 cross infection respiratory care unit Aeinetobacter baumannii multidrug resistance-associated proteins polymerase chain reaction
  • 相关文献

参考文献11

二级参考文献71

共引文献711

同被引文献84

  • 1王涛,郭坤,牛家峰,李庆.呼吸道病原体检测方法的研究进展[J].医学检验与临床,2010(4):95-96. 被引量:19
  • 2卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.
  • 3卫生部卫生法制与监督司.消毒技术规范[S].[S].北京中华人民共和国卫生部,2002..
  • 4卫生部.抗菌药物临床应用指导原则[S].卫医发[2004]285号.
  • 5吕吉云,曲芬.多重耐药微生物及防治对策[M].北京:人民军医出版社,2011:3.
  • 6卫生部,国家中医药管理局总后卫生部.关于施行《抗菌药物临床应用指导原则》的通知[s].卫医发[2004]285号,2004.
  • 7卫生部,国家发展和改革委员会,工业和信息化部,等.关于印发《关于建立国家基本药物制度的实施意见》的通知.卫药政发[2009]78号.
  • 8卫生部办公厅.卫生部办公厅关于继续深入开展全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2012]32号.
  • 9HOU PF,CHEN XY, YAN GF, et al. Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AheM in clinical isolates of Acinetobaeter baumannii[J].Chemother, 2012,58(2) : 152- 158.
  • 10RAJAMOHAN G, SRINIVASAN VB, GEBREYES WA. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii [J]. J Antimicrob Chemother, 2010,65 (9) : 1919- 1925.

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部